Luminex Corp (LMNX)

22.72
0.17 0.75
NASDAQ : Health Care
Prev Close 22.55
Open 22.58
Day Low/High 22.49 / 22.82
52 Wk Low/High 16.16 / 22.85
Volume 163.91K
Avg Volume 215.70K
Exchange NASDAQ
Shares Outstanding 43.55M
Market Cap 993.79M
EPS 0.90
P/E Ratio 30.03
Div & Yield N.A. (N.A)

Latest News

Luminex Corporation Receives FDA Clearance And CE-IVD Mark For The ARIES M1 System

Luminex Corporation Receives FDA Clearance And CE-IVD Mark For The ARIES M1 System

ARIES platform extension provides the significant benefits of ARIES for clinical labs with lower throughput requirements

Luminex To Highlight Latest Additions To Product Portfolio At The 2016 Clinical Virology Symposium

Luminex To Highlight Latest Additions To Product Portfolio At The 2016 Clinical Virology Symposium

Luminex products highlighted in more than 20 poster presentations, and workshop featuring 3 ARIES customers discussing results from their labs

Commit To Purchase Luminex Corp At $20, Earn 15.8% Annualized Using Options

Commit To Purchase Luminex Corp At $20, Earn 15.8% Annualized Using Options

Investors considering a purchase of Luminex Corp shares, but cautious about paying the going market price of $20.04/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $20 strike, which has a bid at the time of this writing of $1.65.

Luminex Corporation Receives FDA Clearance And CE Mark For SYNCT Software

Luminex Corporation Receives FDA Clearance And CE Mark For SYNCT Software

Single Interface for Luminex Data Provides Lab Directors Streamlined Workflow, Improved Data Management, and the Ability to Easily Add New Functionality with Minimal Validation

Strong On High Volume: Luminex (LMNX)

Strong On High Volume: Luminex (LMNX)

Trade-Ideas LLC identified Luminex (LMNX) as a strong on high relative volume candidate

Luminex Corporation Receives FDA Clearance For NxTAG® Respiratory Pathogen Panel

Luminex Corporation Receives FDA Clearance For NxTAG® Respiratory Pathogen Panel

New closed-tube, scalable, 96-well solution meets clinical demand for respiratory testing

Insider Bets Paying Off At LMNX As New 52-Week High Reached

Insider Bets Paying Off At LMNX As New 52-Week High Reached

In trading on Tuesday, shares of Luminex Corp touched a new 52-week high of $21.94/share. That's a 45.78% rise, or $6.89 per share from the 52-week low of $15.05 set back on 02/03/2015.

Luminex Corporation To Feature ARIES System And NxTAG Respiratory Pathogen Panel At AMP Annual Meeting

Luminex Corporation To Feature ARIES System And NxTAG Respiratory Pathogen Panel At AMP Annual Meeting

Recently cleared products will be highlighted at workshops, product demonstrations, events, and posters

Luminex Corporation And Bio-Techne Corporation Extend And Expand Partnership

Luminex Corporation And Bio-Techne Corporation Extend And Expand Partnership

Agreement through 2020; Expands Global Distribution of Award-winning Multiplexing Instrumentation

Affymetrix And Luminex Announce Distribution Agreement For Multiplexed Assay Instrument Platform

Affymetrix And Luminex Announce Distribution Agreement For Multiplexed Assay Instrument Platform

Affymetrix Inc. (NASDAQ: AFFX) and Luminex Corporation (NASDAQ: LMNX) today announced a distribution agreement under which eBioscience, a business unit of Affymetrix, will sell Luminex's MAGPIX ®,...

Luminex Enters Oversold Territory (LMNX)

Luminex Enters Oversold Territory (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Purchase Luminex Corp At $15, Earn 10.3% Annualized Using Options

Commit To Purchase Luminex Corp At $15, Earn 10.3% Annualized Using Options

Investors eyeing a purchase of Luminex Corp stock, but cautious about paying the going market price of $17.22/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2016 put at the $15 strike, which has a bid at the time of this writing of 85 cents.

LMNX: Insiders vs. Shorts

LMNX: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 08/14/2015 settlement date, and Luminex Corp is one of the most shorted stocks of the Russell 3000, based on 10.71 "days to cover" versus the median component at 5.38. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Trade-Ideas: Luminex (LMNX) Is Today's Strong On High Relative Volume Stock

Trade-Ideas: Luminex (LMNX) Is Today's Strong On High Relative Volume Stock

Trade-Ideas LLC identified Luminex (LMNX) as a strong on high relative volume candidate

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: GCO, LMNX, SAFT, XBKS Downgrades: OCLS Initiations: ABY, ASPN, MOBL, MRD, TSE Read on to get TheStreet Quant Ratings' detailed report:

Commit To Purchase Luminex Corp At $15, Earn 9.1% Annualized Using Options

Commit To Purchase Luminex Corp At $15, Earn 9.1% Annualized Using Options

Investors considering a purchase of Luminex Corp stock, but cautious about paying the going market price of $17.50/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2016 put at the $15 strike, which has a bid at the time of this writing of 75 cents.